Exact Mass: 411.2104

Exact Mass Matches: 411.2104

Found 100 metabolites which its exact mass value is equals to given mass value 411.2104, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

1,2-Dihexanoyl-sn-glycero-3-phosphoethanolamine

(2-aminoethoxy)[2,3-bis(hexanoyloxy)propoxy]phosphinic acid

C17H34NO8P (411.2022)

1-(2-(4-(3-Phenyl-2H-1-benzopyran-2-yl)phenoxy)ethyl)piperidine

C28H29NO2 (411.2198)

Sacubitril

3-[(1-{[1,1-biphenyl]-4-yl}-5-ethoxy-4-methyl-5-oxopentan-2-yl)-C-hydroxycarbonimidoyl]propanoate

C24H29NO5 (411.2046)

C23H29N3O4_1H,5H-Imidazo[1,2:1,2]pyrido[2,3-b]indole-2,5(3H)-dione, 7a-(1,1-dimethyl-2-propen-1-yl)-7a,12-dihydro-6,12-dimethoxy-3-(1-methylethyl)

NCGC00380951-01_C23H29N3O4_1H,5H-Imidazo[1,2:1,2]pyrido[2,3-b]indole-2,5(3H)-dione, 7a-(1,1-dimethyl-2-propen-1-yl)-7a,12-dihydro-6,12-dimethoxy-3-(1-methylethyl)-

C23H29N3O4 (411.2158)

Ala Pro Pro Gln

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C18H29N5O6 (411.2118)

Ala Pro Gln Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2118)

Ala Gln Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2118)

Pro Ala Pro Gln

(2S)-4-carbamoyl-2-{[(2S)-1-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}butanoic acid

C18H29N5O6 (411.2118)

Pro Ala Gln Pro

(2S)-1-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2118)

Pro Pro Ala Gln

(2S)-4-carbamoyl-2-[(2S)-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]butanoic acid

C18H29N5O6 (411.2118)

Pro Pro Gln Ala

(2S)-2-[(2S)-4-carbamoyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]propanoic acid

C18H29N5O6 (411.2118)

Pro Gln Ala Pro

(2S)-1-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2118)

Pro Gln Pro Ala

(2S)-2-{[(2S)-1-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C18H29N5O6 (411.2118)

Gln Ala Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2118)

Phe Val Phe

C23H29N3O4 (411.2158)

Gln Pro Ala Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}propanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2118)

Gln Pro Pro Ala

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanoic acid

C18H29N5O6 (411.2118)

PE(6:0/6:0)

Hexanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (R)-

C17H34NO8P (411.2022)

Dihexanoyl-alpha-ph

Hexanoin, 1,2-di-, 3-(dihydrogen phosphate), 2-aminoethyl ester

C17H34NO8P (411.2022)

PE 12:0

Hexanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (R)-

C17H34NO8P (411.2022)

sacubitril

C24H29NO5 (411.2046)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent

FMOC-L-BETA-HOMOTHREONINE(OTBU)

C24H29NO5 (411.2046)

3-Amino-4-chlorobenzoic acid 2-dodecyloxy-1-methyl-2-oxoethyl ester

C22H34ClNO4 (411.2176)

2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic Acid

C24H29NO5 (411.2046)

Fmoc-N-Me-Thr(tBu)-OH

C24H29NO5 (411.2046)

2R,4S-Sacubitril

C24H29NO5 (411.2046)

(2R,4S)-4-([1,1-Biphenyl]-4-ylmethyl)-4-(4-ethoxy-4-oxobutanamido)-2-methylbutanoic acid

C24H29NO5 (411.2046)

AHU-377(Sacubitril)

C24H29NO5 (411.2046)

(2R,3R,4S,7S)-3-[(3R,4R)-3,4-dihydroxypentanoyl]oxy-7-(3-hydroxyphenyl)-7-methoxy-2,4-dimethylheptanoate

C21H31O8- (411.2019)

D009676 - Noxae > D011042 - Poisons > D008235 - Lyngbya Toxins D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins

2-azaniumylethyl (2R)-2,3-bis(hexanoyloxy)propyl phosphate

C17H34NO8P (411.2022)

2,11-Dimethoxy-9-(2-methylbut-3-en-2-yl)-14-propan-2-yl-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione

C23H29N3O4 (411.2158)

1-Phenyl-4-[[1-(phenylmethyl)-5-tetrazolyl]-(3-pyridinyl)methyl]piperazine

C24H25N7 (411.2171)

N,N-(6-((4-(hydroxy(phenyl)methyl)phenyl)amino)-6-oxohexane-1,5-diyl)diacetamide

C23H29N3O4 (411.2158)

2-(9-Oxononanoyl)-sn-glycero-3-phosphocholine

C17H34NO8P (411.2022)

Val-Phe-Phe

C23H29N3O4 (411.2158)

Phe-val-phe

C23H29N3O4 (411.2158)

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

(2R,3R,3aS,9bS)-7-(cyclopenten-1-yl)-1-(cyclopropanecarbonyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C23H29N3O4 (411.2158)

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-1-[cyclopropyl(oxo)methyl]-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C23H29N3O4 (411.2158)

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.2158)

Phe-Phe-Val

C23H29N3O4 (411.2158)

alpha-L-Rhap-(1->3)-beta-D-GlcpO[CH2]5NH2

C17H33NO10 (411.2104)

N-[(2S)-1-oxo-1-[[(2S)-1-oxo-1-[2-(2,4,5-trihydroxyphenyl)ethylamino]propan-2-yl]amino]propan-2-yl]carbamic acid tert-butyl ester

C19H29N3O7 (411.2005)

Lnape 9:0/N-3:0

C17H34NO8P (411.2022)

Lnape 6:0/N-6:0

C17H34NO8P (411.2022)

Lnape 3:0/N-9:0

C17H34NO8P (411.2022)

Lnape 7:0/N-5:0

C17H34NO8P (411.2022)

Lnape 5:0/N-7:0

C17H34NO8P (411.2022)

Lnape 4:0/N-8:0

C17H34NO8P (411.2022)

Lnape 8:0/N-4:0

C17H34NO8P (411.2022)

Lnape 2:0/N-10:0

C17H34NO8P (411.2022)

Lnape 10:0/N-2:0

C17H34NO8P (411.2022)

(3-Acetyloxy-2-heptanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C17H34NO8P (411.2022)

(2-Hexanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C17H34NO8P (411.2022)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] heptanoate

C17H34NO8P (411.2022)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] octanoate

C17H34NO8P (411.2022)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] nonanoate

C17H34NO8P (411.2022)

(3-Butanoyloxy-2-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C17H34NO8P (411.2022)

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] decanoate

C17H34NO8P (411.2022)

1,2-dihexanoyl-sn-glycero-3-phosphoethanolamine

C17H34NO8P (411.2022)

LPC 9:1;O

C17H34NO8P (411.2022)

PE 10:0/2:0

C17H34NO8P (411.2022)

ST 22:6;O3;Gly

C24H29NO5 (411.2046)

ST 19:2;O2;Tau

C21H33NO5S (411.2079)

MK-6884

C25H25N5O (411.2059)

MK-6884 is a M4 muscarinic receptor positive allosteric modulator (PAM) with a Ki value of 0.19 nM. MK-6884 can be used for the research of the neurodegenerative diseases. MK-6884 can be conveniently radiolabeled with carbon-11 and as a positron emission tomography (PET) imaging agent[1].

(8as)-6,7-bis(3,4-dimethoxyphenyl)-2,3,5,8-tetrahydro-1h-indolizin-8a-ol

C24H29NO5 (411.2046)

6,7-bis(3,4-dimethoxyphenyl)-2,3,5,8-tetrahydro-1h-indolizin-8a-ol

C24H29NO5 (411.2046)

6-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-8-oxa-4-azatricyclo[7.4.0.0²,⁷]trideca-1(9),2,4,6-tetraene-5,10,11-triol

C24H29NO5 (411.2046)

(10r,11r)-6-[(1r,2r,4as,6r,8ar)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-8-oxa-4-azatricyclo[7.4.0.0²,⁷]trideca-1(9),2,4,6-tetraene-5,10,11-triol

C24H29NO5 (411.2046)

(2r,3r,4s,5s,6r)-1-butyl-2-(hydroxymethyl)-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)piperidine-3,4,5-triol

C17H33NO10 (411.2104)

2-[(1-hydroxy-2-{[1-hydroxy-2-(methylamino)-3-phenylpropylidene]amino}-4-methylpentylidene)amino]benzoic acid

C23H29N3O4 (411.2158)

2-{[(2s)-1-hydroxy-2-{[(2r)-1-hydroxy-2-(methylamino)-3-phenylpropylidene]amino}-4-methylpentylidene]amino}benzoic acid

C23H29N3O4 (411.2158)

4-{5-[(1r,2r,4as,6r,8ar)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4,6-dihydroxypyridin-3-yl}-4-hydroxycyclohex-2-en-1-one

C24H29NO5 (411.2046)

4-[5-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-4,6-dihydroxypyridin-3-yl]-4-hydroxycyclohex-2-en-1-one

C24H29NO5 (411.2046)